SPY312.23+1.71 0.55%
DIA258.42+1.11 0.43%
IXIC10,207.63+53.00 0.52%

HC Wainwright & Co. Maintains Buy on Sangamo Therapeutics, Lowers Price Target to $14

HC Wainwright & Co. maintains Sangamo Therapeutics (NASDAQ:SGMO) with a Buy and lowers the price target from $16 to $14.

Benzinga · -
HC Wainwright & Co. maintains Sangamo Therapeutics (NASDAQ: SGMO) with a Buy and lowers the price target from $16 to $14.